Feed-forward inhibition of cd73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Vieira, Cátia ^a   Magalhães Cardoso, Maria Teresa ^a   Ferreirinha, Fátima ^a   Silva, Isabel ^a   Dias, Ana Sofia ^a   Pelletier, Julie ^b   Sévigny, Jean ^b,c   Correia De Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Université Laval   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ATIPAMEZOLE; ECTO 5' NUCLEOTIDASE; TRAMADOL; 5' NUCLEOTIDASE; ADENOSINE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME RELEASE; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; ILEITIS; ILEUM LONGITUDINAL MUSCLE-MYENTERIC PLEXUS PREPARATION; IN VIVO STUDY; MALE; NERVE CELL; NERVE ENDING; NEUROMODULATION; NONHUMAN; POSTOPERATIVE PAIN; RAT; SYNAPSE; TISSUE DISTRIBUTION; ANIMAL; METABOLISM;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; FEMALE; ILEITIS; MALE; RATS; TRINITROBENZENESULFONIC ACID;

EID: 84907247079     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/254640     Document Type: Article

References (76)

1. Sharkey K. A., Kroese B. A., Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anatomical Record 2001 262 79 90
2. Vasina V., Barbara G., Talamonti L., Stanghellini V., Corinaldesi R., Tonini M., De Ponti F., De Giorgio R., Enteric neuroplasticity evoked by inflammation. Autonomic Neuroscience 2006 126-127 264 272 10.1016/j.autneu.2006.02.025 2-s2.0-33744512952
3. Pontell L., Castelucci P., Bagyánszki M., Jovic T., Thacker M., Nurgali K., Bron R., Furness J. B., Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation. Virchows Archiv 2009 455 1 55 65 10.1007/s00428-009-0795-x 2-s2.0-67650735258
4. Roberts J. A., Lukewich M. K., Sharkey K. A., Furness J. B., Mawe G. M., Lomax A. E., The roles of purinergic signaling during gastrointestinal inflammation. Current Opinion in Pharmacology 2012 12 6 659 666 10.1016/j.coph.2012.09.011 2-s2.0-84870484811
5. Kukulski F., Lévesque SA., Sévigny J., Impact of ectoenzymes on P2 and P1 receptor signaling. Advances in Pharmacology 2011 61 263 299
6. White T. D., Leslie R. A., Depolarization-induced release of adenosine 5'-triphosphate from isolated varicosities derived from the myenteric plexus of the guinea pig intestine. Journal of Neuroscience 1982 2 2 206 215 2-s2.0-0020037715
7. 1-Receptor-mediated effect of adenosine on the release of acetylcholine from the myenteric plexus: Role and localization of ecto-ATPase and 5′-nucleotidase. Neuroscience 1995 67 1 159 168 10.1016/0306-4522(94)00585-S 2-s2.0-0029064938
8. Kukulski F., Lévesque S. A., Lavoie É. G., Lecka J., Bigonnesse F., Knowles A. F., Robson S. C., Kirley T. L., Sévigny J., Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signalling 2005 1 2 193 204 10.1007/s11302-005-6217-x 2-s2.0-16444369930
9. Stefan C., Jansen S., Bollen M., NPP-type ectophosphodiesterases: unity in diversity. Trends in Biochemical Sciences 2005 30 10 542 550 10.1016/j.tibs.2005.08.005 2-s2.0-25144473903
10. Gendron F. P., Benrezzak O., Krugh B. W., Kong Q., Weisman G. A., Beaudoin A. R., Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Current Drug Targets 2002 3 3 229 245 10.2174/1389450023347713 2-s2.0-0036001053
11. Sträter N., Ecto-5′-nucleotidase: structure function relationships. Purinergic Signalling 2006 2 2 343 350 10.1007/s11302-006-9000-8 2-s2.0-34047250594
12. Duarte-Araújo M., Nascimento C., Timóteo M. A., Magalhães-Cardoso M. T., Correia-de-Sá P., Relative contribution of ecto-ATPase and ecto-ATPDase pathways to the biphasic effect of ATP on acetylcholine release from myenteric motoneurons. British Journal of Pharmacology 2009 156 3 519 533 10.1111/j.1476-5381.2008.00058.x 2-s2.0-65449140559
13. Milusheva E., Sperlagh B., Kiss B., Szporny L., Pasztor E., Papasova M., Vizi E. S., Inhibitory effect of hypoxic condition on acetylcholine release is partly due to the effect of adenosine released from the tissue. Brain Research Bulletin 1990 24 3 369 373 10.1016/0361-9230(90)90091-D 2-s2.0-0025265690
14. de Man J. G., Seerden T. C., de Winter B. Y., van Marck E. A., Herman A. G., Pelckmans P. A., Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. British Journal of Pharmacology 2003 139 1 172 184 10.1038/sj.bjp.0705218 2-s2.0-0038392662
15. Nicholls J., Brownhill V. R., Hourani S. M. O., Characterization of P1-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae. British Journal of Pharmacology 1996 117 1 170 174 2-s2.0-0029671011
16. Vieira C., Ferreirinha F., Silva I., Duarte-Araújo M., Correia-de-Sá P., Localization and function of adenosine receptor subtypes at the longitudinal muscle-myenteric plexus of the rat ileum. Neurochemistry International 2011 59 7 1043 1055 10.1016/j.neuint.2011.08.016 2-s2.0-80055012521
17. Moneta N. A., McDonald T. J., Cook M. A., Endogenous adenosine inhibits evoked substance P release from perifused networks of myenteric ganglia. American Journal of Physiology-Gastrointestinal and Liver Physiology 1997 272 1 G38 G45 2-s2.0-0031035620
18. 1receptors. British Journal of Pharmacology 2004 141 6 925 934 10.1038/sj.bjp.0705697 2-s2.0-1942472540
19. Correia-de-Sá P., Adães S., Timóteo M. A., Vieira C., Magalhães-Cardoso T., Nascimento C., Duarte-Araújo M., Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Autonomic Neuroscience: Basic and Clinical 2006 126-127 211 224 10.1016/j.autneu.2006.02.004 2-s2.0-33744517669
20. Pettengill M., Robson S., Tresenriter M., Millán J. L., Usheva A., Bingham T., Belderbos M., Bergelson I., Burl S., Kampmann L. G., Kollmann T., Bont L., Levy O., Soluble ecto-5′-nucleotidase (5′-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. The Journal of Biological Chemistry 2013 288 38 27315 27326 10.1074/jbc.M113.484212
21. Franco R., Casadó V., Ciruela F., Saura C., Mallol J., Canela E. I., Lluis C., Cell surface adenosine deaminase: much more than an ectoenzyme. Progress in Neurobiology 1997 52 4 283 294 10.1016/S0301-0082(97)00013-0 2-s2.0-0030740773
22. Marquardt D. L., Gruber H. E., Wasserman S. I., Adenosine release from stimulated mast cells. Proceedings of the National Academy of Sciences of the United States of America 1984 81 19I 6192 6196 2-s2.0-0006151557
23. Stead R. H., Dixon M. F., Bramwell N. H., Riddell R. H., Bienenstock J., Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989 97 3 575 585 2-s2.0-0024344214
24. Bogers J., Moreels T., de Man J., Vrolix G., Jacobs W., Pelckmans P., van Marck E., Schistosoma mansoni causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine. Neurogastroenterology & Motility 2000 12 431 440
25. Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M., del Tacca M., Blandizzi C., Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacology and Therapeutics 2008 120 3 233 253 10.1016/j.pharmthera.2008.08.010 2-s2.0-56049100674
26. Jergens A. E., Inflammatory bowel disease. Current perspectives. Veterinary Clinics of North America-Small Animal Practice 1999 29 2 501 521 2-s2.0-0032925692
27. Engel M. A., Kellermann C. A., Rau T., Burnat G., Hahn E. G., Konturek P. C., Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. Journal of Physiology and Pharmacology 2008 59 4 673 689 2-s2.0-58449083070
28. Wirtz S., Neurath M. F., Mouse models of inflammatory bowel disease. Advanced Drug Delivery Reviews 2007 59 11 1073 1083 10.1016/j.addr.2007.07.003 2-s2.0-35348982262
29. Paton W. D., Vizi E. S., The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. British Journal of Pharmacology 1969 35 1 10 28 2-s2.0-0014446524
30. Costa M., Brookes S. J. H., Steele P. A., Gibbins I., Burcher E., Kandiah C. J., Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience 1996 75 3 949 967 10.1016/0306-4522(96)00275-8 2-s2.0-0030561280
31. 2+mobilization and cell proliferation. The Journal of Biological Chemistry 2013 288 27571 27583
32. 6receptors. Biochemical Pharmacology 2014 87 371 379
33. Enjyoji K., Sévigny J., Lin Y., Frenette P. S., Christie P. D., Am Esch J. S. II, Imai M., Edelberg J. M., Rayburn H., Lech M., Beeler D. L., Csizmadia E., Wagner D. D., Robson S. C., Rosenberg R. D., Targeted disruption of cd39 /ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Medicine 1999 5 9 1010 1017 10.1038/12447 2-s2.0-0345540629
34. Heine P., Braun N., Sévigny J., Robson S. C., Servos J., Zimmermann H., The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. European Journal of Biochemistry 2001 268 2 364 373 10.1046/j.1432-1033.2001.01896.x
35. MartínSatué M., Lavoie E. G., Pelletier J., Localization of plasma membrane bound NTPDases in the murine reproductive tract. Histochemistry and Cell Biology 2009 131 615 628
36. Bartel D. L., Sullivan S. L., Lavoie É. G., Sévigny J., Finger T. E., Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds. Journal of Comparative Neurology 2006 497 1 1 12 10.1002/cne.20954 2-s2.0-33744928130
37. Fausther M., Lecka J., Kukulski F., Lévesque S. A., Pelletier J., Zimmermann H., Dranoff J. A., Sévigny J., Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007 292 3 G785 G795 10.1152/ajpgi.00293.2006 2-s2.0-33947319312
38. Moreels T. G., De Man J. G., Dick J. M. C., Nieuwendijk R. J., de Winter B. Y., Lefebvre R. A., Herman A. G., Pelckmans P. A., Effect of TNBS-induced morphological changes on pharmacological contractility of the rat ileum. European Journal of Pharmacology 2001 423 2-3 211 222 10.1016/S0014-2999(01)01088-3 2-s2.0-0035816442
39. Depoortere I., Thijs T., Peeters T. L., Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis. British Journal of Pharmacology 2002 135 8 2011 2019 2-s2.0-0036254897
40. Strong D. S., Cornbrooks C. F., Roberts J. A., Hoffman J. M., Sharkey K. A., Mawe G. M., Purinergic neuromuscular transmission is selectively attenuated in ulcerated regions of inflamed guinea pig distal colon. Journal of Physiology 2010 588 5 847 859 10.1113/jphysiol.2009.185082 2-s2.0-77950522750
41. 2Aadenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 2005 129 1 26 33 10.1053/j.gastro.2005.05.032 2-s2.0-22344435384
42. 2Aadenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infection and Immunity 2006 74 5 2606 2612 10.1128/IAI.74.5.2606-2612.2006 2-s2.0-33646356197
43. 2Aadenosine receptors in the control of colonic neuromuscular function in experimental colitis. European Journal of Pharmacology 2011 650 2-3 639 649 10.1016/j.ejphar.2010.10.041 2-s2.0-78651068267
44. Antonioli L., Pacher P., Vizi E. S., Haskó G., CD39 and CD73 in immunity and inflammation. Trends in Molecular Medicine 2013 19 6 355 367 10.1016/j.molmed.2013.03.005 2-s2.0-84878614399
45. Neshat S., Devries M., Barajas-Espinosa A. R., Skeith L., Chisholm S. P., Lomax A. E., Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009 296 2 G399 G405 10.1152/ajpgi.90450.2008 2-s2.0-59449106193
46. Giron M. C., Bin A., Brun P., Etteri S., Bolego C., Florio C., Gaion R. M., Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway. Gastroenterology 2008 134 4 1116 1126 10.1053/j.gastro.2008.01.030 2-s2.0-41349091642
47. 2Areceptor facilitation of acetylcholine release at rat motor nerve endings. Journal of Physiology 2003 549 2 399 408 10.1113/jphysiol.2003.040410 2-s2.0-0038511040
48. Braun N., Sévigny J., Robson S. C., Hammer K., Hanani M., Zimmermann H., Association of the ecto -ATPase NTPDase2 with glial cells of the peripheral nervous system. GLIA 2004 45 2 124 132 10.1002/glia.10309 2-s2.0-1042291303
49. Lavoie E. G., Gulbransen B. D., Martín-Satué M., Aliagas E., Sharkey K. A., Sévigny J., Ectonucleotidases in the digestive system: focus on NTPDase3 localization. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011 300 4 G608 G620 10.1152/ajpgi.00207.2010 2-s2.0-79955051088
50. Martin M., Huguet J., Centelles J. J., Franco R., Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex: possible role of adenosine deaminase as costimulatory molecule. The Journal of Immunology 1995 155 10 4630 4643 2-s2.0-0028790702
51. Conlon B. A., Law W. R., Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clinical and Experimental Immunology 2004 138 1 14 20 10.1111/j.1365-2249.2004.02591.x 2-s2.0-4644336281
52. Lakhan S. E., Kirchgessner A., Neuroinflammation in inflammatory bowel disease. Journal of Neuroinflammation 2010 7, article 37 10.1186/1742-2094-7-37 2-s2.0-77955130380
53. 3receptors. Journal of Pharmacology and Experimental Therapeutics 2010 335 2 434 442 10.1124/jpet.110.171223 2-s2.0-78149233636
54. Robson S. C., Sévigny J., Zimmermann H., The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006 2 2 409 430 10.1007/s11302-006-9003-5 2-s2.0-33846436678
55. Louis N. A., Robinson A. M., MacManus C. F., Karhausen J., Scully M., Colgan S. P., Control of IFN- α A by CD73: implications for mucosal inflammation. The Journal of Immunology 2008 180 6 4246 4255 10.4049/jimmunol.180.6.4246 2-s2.0-44849106271
56. Sotnikov I., Louis N. A., CD73-dependent regulation of interferon AlphaA and interleukin-10 in the inflamed mucosa. The Scientific World Journal 2010 10 2167 2180 10.1100/tsw.2010.203 2-s2.0-78650273587
57. Siegmund B., Rieder F., Albrich S., Adenosine kinase inhibitor GP515 improves experimental colitis in mice. Journal of Pharmacology and Experimental Therapeutics 2001 296 99 105
58. Mabley J. G., Pacher P., Liaudet L., Soriano F. G., Hasko G., Marton A., Szabo C., Salzman A. L., Inosine reduces inflammation and improves survival in a murine model of colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003 284 1 G138 G144 2-s2.0-0037230080
59. Cronstein B. N., Adenosine, an endogenous anti-inflammatory agent. Journal of Applied Physiology 1994 76 1 5 13 2-s2.0-0027983055
60. Yegutkin G. G., Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta 2008 1783 5 673 694 10.1016/j.bbamcr.2008.01.024 2-s2.0-41949083203
61. Burnstock G., Williams M., P2 purinergic receptors: modulation of cell function and therapeutic potential. Journal of Pharmacology and Experimental Therapeutics 2000 295 3 862 869 2-s2.0-0033680583
62. 2Breceptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats. British Journal of Pharmacology 2014 171 1314 1329
63. O'Brien K. D., Pineda C., Chiu W. S., Bowen R., Deeg M. A., Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. Journal of the American Heart Association 1999 99 22 2876 2882 10.1161/01.CIR.99.22.2876
64. Burnstock G., Lavin S., Interstitial cells of Cajal and purinergic signalling. Autonomic Neuroscience 2002 97 1 68 72 10.1016/S1566-0702(02)00005-X 2-s2.0-0037129142
65. Diezmos E. F., Sandow S. L., Markus I., Shevy Perera D., Lubowski D. Z., King D. W., Bertrand P. P., Liu L., Expression and localization of pannexin-1 hemichannels in human colon in health and disease. Neurogastroenterology and Motility 2013 25 6 e395 e405 10.1111/nmo.12130 2-s2.0-84878014119
66. Gulbransen B. D., Bashashati M., Hirota S. A., Gui X., Roberts J. A., MacDonald J. A., Muruve D. A., McKay D. M., Beck P. L., Mawe G. M., Thompson R. J., Sharkey K. A., Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nature Medicine 2012 18 4 600 604 10.1038/nm.2679 2-s2.0-84863393008
67. Sanger G. J., New target profiling for gastrointestinal disorders: where are we going? Current Opinion in Pharmacology 2012 12 6 629 631 10.1016/j.coph.2012.10.006 2-s2.0-84870532578
68. Fausther M., Lecka J., Soliman E., Kauffenstein G., Pelletier J., Sheung N., Dranoff J. A., Sévigny J., Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012 302 4 447 459 10.1152/ajpgi.00165.2011 2-s2.0-84856742916
69. Cunha R. A., Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochemical Research 2001 26 8-9 979 991 10.1023/A:1012392719601 2-s2.0-0034753234
70. Guzman J., Yu J. G., Suntres Z., Bozarov A., Cooke H., Javed N., Auer H., Palatini J., Hassanain H. H., Cardounel A. J., Javed A., Grants I., Wunderlich J. E., Christofi F. L., ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflammatory Bowel Diseases 2006 12 8 766 789 10.1097/00054725-200608000-00014 2-s2.0-33747436925
71. Christofi F. L., Unlocking mysteries of gut sensory transmission: is adenosine the key? News in Physiological Sciences 2001 16 5 201 207 2-s2.0-0035489065
72. Cristalli G., Costanzi S., Lambertucci C., Lupidi G., Vittori S., Volpini R., Camaioni E., Adenosine deaminase: functional implications and different classes of inhibitors. Medicinal Research Reviews 2001 2 105 128
73. Nagy J. I., Geiger J. D., Staines W. A., Adenosine deaminase and purinergic neuroregulation. Neurochemistry International 1990 16 3 211 221 10.1016/0197-0186(90)90093-9 2-s2.0-0025269315
74. Nagy J. I., Yamamoto T., Uemura H., Schrader W. P., Adenosine deaminase in rodent median eminence: detection by antibody to the mouse enzyme and co-localization with adenosine deaminase-complexing protein (CD26). Neuroscience 1996 73 2 459 471 10.1016/0306-4522(96)00049-8 2-s2.0-0029949935
75. Ungerer J. P. J., Oosthuizen H. M., Bissbort S. H., Vermaak W. J. H., Serum adenosine deaminase: isoenzymes and diagnostic application. Clinical Chemistry 1992 38 7 1322 1326 2-s2.0-0026672207
76. Antonioli L., Fornai M., Colucci R., Ghisu N., Da Settimo F., Natale G., Kastsiuchenka O., Duranti E., Virdis A., Vassalle C., La Motta C., Mugnaini L., Breschi M. C., Blandizzi C., Del Tacca M., Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. Journal of Pharmacology and Experimental Therapeutics 2007 322 2 435 442 10.1124/jpet.107.122762 2-s2.0-34547104376